VanEck Vectors Coal ETF KOL
94.92 USD 0.00 (+0.00%)
Dec 14, 2020, 3:59 PM EST
94.90 Day range 95.50
54.10 52-week range 99.33
- Market cap
- 35.33M
- Volume
- 56.46K
- Avg volume
- 8.23K
- Open
- 95.03
- Previous close
- 94.92
- Day's range
- 94.90 – 95.50
- 52-week range
- 54.10 – 99.33
No chart data for this range yet.
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 94.92
- 200-day average
- 81.72
About VanEck Vectors Coal ETF
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® Global Coal Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes companies in the global coal industry that generate at least 50% of their revenues from coal operation (production, mining and cokeries), transportation of coal, production of coal mining equipment as well as from storage and trade. It is non-diversified.
News
Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026
enGene to Host KOL Webinar on October 15, 2026
vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes and the Cadisegliatin Phase 3 Program on October 20, 2026
Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026
Sagimet Biosciences to Host Virtual KOL Event, “Denifanstat Update: 52-Week Data from Phase 3 Open-Label Extension in China and Planned AURORA Phase 3 Clinical Trial in US” on September 30, 2026
Quince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026
Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026
Rapport Therapeutics to Host Virtual KOL Event on the Unmet Need in Bipolar Mania and the RAP-219 Clinical Program
Eikon Therapeutics to Participate in KOL Event on Therapeutic Use of PARP Inhibitors in Oncology Hosted by Cantor Fitzgerald
Your note
Sign in to keep a note on KOL — it syncs with the Stock Master app.
